(90 days)
Not Found
No
The description focuses on the mechanical and physical properties of a catheter and balloon, with no mention of software, algorithms, or data processing that would indicate AI/ML.
No.
A therapeutic device is used to treat or cure a disease or condition. This device is indicated for facilitating the insertion and guidance of intravascular catheters, providing temporary vascular occlusion, and acting as a conduit for retrieval devices, which are all diagnostic or procedural support functions, not therapeutic treatments.
No
The device is a catheter designed for facilitating the insertion and guidance of other intravascular catheters and providing temporary vascular occlusion, not for diagnosing conditions.
No
The device description clearly details a physical catheter with a balloon, radiopaque marker, and luer hub, indicating it is a hardware device, not software-only. The performance studies also focus on physical properties and performance of the hardware.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes a device used in vivo (within the body) to facilitate the insertion and guidance of other catheters and provide temporary vascular occlusion. This is a procedural device used during medical interventions.
- Device Description: The description details a physical catheter with a balloon, designed for insertion into blood vessels. This aligns with an in vivo device.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening. IVDs typically involve analyzing biological samples outside the body.
Therefore, the Concentric Balloon Guide Catheter is an invasive medical device used for procedures within the body, not an IVD.
N/A
Intended Use / Indications for Use
The Modified Balloon Guide Catheter is indicated for use in facilitating the insertion and guidance of an intravascular catheter into a selected blood vessel in the peripheral and neuro vascular systems. The balloon provides temporary vascular occlusion during these and other angiographic procedures. The Balloon Guide Catheter is also indicated for use as a conduit for Retrieval devices.
Product codes (comma separated list FDA assigned to the subject device)
DQY
Device Description
Like the predicate device, the Modified Balloon Guide Catheter is a coaxial-lumen, braid-reinforced, variable stiffness catheter designed for use in facilitating the insertion and guidance of an intravascular catheter into a selected blood vessel in the peripheral and neuro vascular systems. A radiopaque marker is included on the distal end for angiographic visualization. A compliant balloon is mounted on the distal end to provide temporary vascular occlusion during angiographic procedures. A bifurcated luer hub on the proximal end allows attachments for flushing, inflation and aspiration. Balloon Guide Catheter dimensions and maximum recommended balloon inflation volume are indicated on product label.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
peripheral and neuro vascular systems
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
- Simulated Use Testing: the ability of the device and accessories to be used per procedural. instructions outlined in the Instructions for Use in a neurovascular model was successfully evaluated.
- Balloon Testing: the symmetry and compliance of the distal balloon; balloon inflation and. deflation; balloon fatigue strength; constrained balloon burst and leakage were successfully evaluated.
- Tensile Testing: the mechanical integrity of the device under tensile loads was successfully. evaluated.
- Tip Deflection Force Testing: the force to deflect the distal tip of the device was successfully. evaluated.
- Torque Transmission Testing: the torque transmission ratio was successfully evaluated..
- Leak Testing: the device resistance to leaking during use was successfully evaluated..
- Kink Resistance: the ability of the device shaft to resist kinking was successfully evaluated. A.
- Dilator Shape Retention: the shape retention of the dilator tip was successfully evaluated..
- Peel Strength: the force to peel the Peel-Away Sheath was successfully evaluated.
The following biocompatibility tests were performed on the device including the dilator; results for all tests met the pre-determined acceptance criteria.
- Sensitization/Maximization
- Cytotoxicity.
- Intracutaenous Reactivity.
- Systemic Toxicity/Systemic Injection Test.
- . Systemic Toxicity/Rabbit Pyrogen Test
- Hemocompatibility/Hemolysis.
- Hemocompatibility/Complement Activation.
- Hemocompatibility/in vivo Thrombogenicity
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).
0
510(k) Summary
| Trade Name: | Modified Balloon Guide Catheter | NOV 21 2012 | ||
|---|---|---|---|---|
| Common Name: | Percutaneous Catheter | |||
| Classification Name: | Percutaneous Catheter, 21CFR 870.1250 Class II | |||
| Submitter: | Concentric Medical, Inc. | |||
| 301 E. Evelyn Avenue | ||||
| Mountain View, CA 94041 | ||||
| Tel 650-938-2100 | ||||
| Fax 650-237-5230 | ||||
| Facility Registration #2954917 | ||||
| Contact: | Christina Rowe | |||
| Manager, Regulatory Affairs | ||||
| Date Prepared: | November 16, 2012 | |||
| Predicate Device: | Concentric Balloon Guide Catheter (K112404) |
Device Description
Like the predicate device, the Modified Balloon Guide Catheter is a coaxial-lumen, braid-reinforced, variable stiffness catheter designed for use in facilitating the insertion and guidance of an intravascular catheter into a selected blood vessel in the peripheral and neuro vascular systems. A radiopaque marker is included on the distal end for angiographic visualization. A compliant balloon is mounted on the distal end to provide temporary vascular occlusion during angiographic procedures. A bifurcated luer hub on the proximal end allows attachments for flushing, inflation and aspiration. Balloon Guide Catheter dimensions and maximum recommended balloon inflation volume are indicated on product label.
Indications for Use
The Indications for Use are the identical to that of the predicate device and are as follows:
The Modified Balloon Guide Catheter is indicated for use in facilitating the insertion and guidance of an intravascular catheter into a selected blood vessel in the peripheral and neuro vascular systems. The balloon provides temporary vascular occlusion during these and other angiographic procedures. The Balloon Guide Catheter is also indicated for use as a conduit for Retrieval devices.
1
Technological Characteristics
The Modified Balloon Guide Catheters have the same technological characteristics as the predicate device. Minor modifications have been made to the device materials and design which were successfully evaluated during verification and validation testing.
Testing Summary
The results of verification and validation conducted on the Modified Balloon Guide Catheter demonstrate that it performs as designed, is suitable for its intended use and is substantially equivalent to the predicate device. Specifically, the following tests were performed on the proposed device and accessories:
- Simulated Use Testing: the ability of the device and accessories to be used per procedural . instructions outlined in the Instructions for Use in a neurovascular model was successfully evaluated.
- Balloon Testing: the symmetry and compliance of the distal balloon; balloon inflation and . deflation; balloon fatigue strength; constrained balloon burst and leakage were successfully evaluated.
- Tensile Testing: the mechanical integrity of the device under tensile loads was successfully . evaluated.
- Tip Deflection Force Testing: the force to deflect the distal tip of the device was successfully . evaluated.
- Torque Transmission Testing: the torque transmission ratio was successfully evaluated. .
- Leak Testing: the device resistance to leaking during use was successfully evaluated. .
- Kink Resistance: the ability of the device shaft to resist kinking was successfully evaluated. A .
- Dilator Shape Retention: the shape retention of the dilator tip was successfully evaluated. .
- Peel Strength: the force to peel the Peel-Away Sheath was successfully evaluated. .
The following biocompatibility tests were performed on the device including the dilator; results for all tests met the pre-determined acceptance criteria.
- Sensitization/Maximization ●
- Cytotoxicity .
- Intracutaenous Reactivity .
- Systemic Toxicity/Systemic Injection Test .
- . Systemic Toxicity/Rabbit Pyrogen Test
- Hemocompatibility/Hemolysis .
- Hemocompatibility/Complement Activation .
- Hemocompatibility/in vivo Thrombogenicity
2
Summary of Substantial Equivalence
The Modified Balloon Guide Catheter is substantially equivalent to the predicate device with regard to device design, intended use, and patient population. The conclusions drawn from the verification and validation testing conducted using the Modified Balloon Guide Catheter demonstrate that it performs as designed, is suitable for its intended use and is substantially equivalent to the legally marketed device.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines representing its wings or feathers. The eagle is positioned to the right of a circular arrangement of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The text is arranged around the top and left side of the circle.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002
November 21, 2012
Concentric Medical, Inc. c/o Ms. Kirsten Valley Manager of Regulatory Affairs 301 East Evelyn Ave. Mountain View, CA 94041
Re: K122581
Trade/Device Name: Concentric Balloon Guide Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous catheter Regulatory Class: Class II Product Code: DQY Dated: October 9, 2012 Received: October 10, 2012
Dear Ms. Valley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Joyce M. Whang
for
Victor Krauthamer, Ph.D. Acting Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): K122581
Device Name: Concentric Balloon Guide Catheter
Indications For Use:
The Concentric Balloon Guide Catheter is indicated for use in facilitating the insertion and guidance of intravascular catheter into a selected blood vessel in the peripheral and neuro vascular systems. The balloon provides temporary vascular occlusion during these and other angiographic procedures. The Balloon Guide Catheter is also indicated for use as a conduit for retrieval devices.
Prescription Use XX : (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Joyce M. Whang
(Division Sign Off)
Division of Neurological and Physical Medicine Devices (DNPMD)
510(k) Number K122581
Page 1 of 1